$224.91
+0 (+0%)
At Close: May 27, 2022
Myokardia Inc (NASDAQ:MYOK) CEO Anastasios Gianakakos Sells 1,000 Shares
08:46am, Tuesday, 21'st Apr 2020
Myokardia Inc (NASDAQ:MYOK) CEO Anastasios Gianakakos sold 1,000 shares of Myokardia stock in a transaction dated Thursday, April 16th. The shares were sold at an average price of $55.00, for a total
Myokardia (NASDAQ:MYOK) Raised to Hold at BidaskClub
07:40am, Saturday, 18'th Apr 2020
Myokardia (NASDAQ:MYOK) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Saturday, BidAskClub reports. Sev
Myokardia (NASDAQ:MYOK) Stock Price Up 5.7% Following Analyst Upgrade
05:40am, Friday, 17'th Apr 2020
Myokardia Inc (NASDAQ:MYOK) shares traded up 5.7% during trading on Thursday after Morgan Stanley raised their price target on the stock from $76.00 to $83.00. Morgan Stanley currently has an overweig
MyoKardia (MYOK) Gets a Buy Rating from Morgan Stanley
03:33pm, Wednesday, 15'th Apr 2020
Morgan Stanley analyst Jeffrey Hung maintained a Buy rating on MyoKardia (MYOK) today and set a price target of $83.00. The company's shares closed last
Should You Be Worried About Insider Transactions At MyoKardia, Inc. (NASDAQ:MYOK)?
12:57pm, Monday, 13'th Apr 2020
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...
Anastasios Gianakakos Sells 1,500 Shares of Myokardia Inc (NASDAQ:MYOK) Stock
09:34am, Sunday, 12'th Apr 2020
Myokardia Inc (NASDAQ:MYOK) CEO Anastasios Gianakakos sold 1,500 shares of the firm’s stock in a transaction that occurred on Wednesday, April 8th. The shares were sold at an average price of $50.00
Taylor C. Harris Sells 1,305 Shares of Myokardia Inc (NASDAQ:MYOK) Stock
10:58am, Thursday, 09'th Apr 2020
Myokardia Inc (NASDAQ:MYOK) CFO Taylor C. Harris sold 1,305 shares of the firm’s stock in a transaction that occurred on Monday, April 6th. The stock was sold at an average price of $46.99, for a to
Cubist Systematic Strategies LLC Buys 770 Shares of Myokardia Inc (NASDAQ:MYOK)
10:38am, Wednesday, 08'th Apr 2020
Cubist Systematic Strategies LLC increased its stake in shares of Myokardia Inc (NASDAQ:MYOK) by 7.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange
Bank of New York Mellon Corp Has $15.43 Million Stake in Myokardia Inc (NASDAQ:MYOK)
10:38am, Wednesday, 08'th Apr 2020
Bank of New York Mellon Corp increased its holdings in shares of Myokardia Inc (NASDAQ:MYOK) by 11.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securi
Edited Transcript of MYOK earnings conference call or presentation 9-May-19 8:30pm GMT
06:16pm, Tuesday, 07'th Apr 2020
Q1 2019 MyoKardia Inc Earnings Call
Are Options Traders Betting on a Big Move in MyoKardia (MYOK) Stock?
12:32pm, Tuesday, 07'th Apr 2020
Investors need to pay close attention to MyoKardia (MYOK) stock based on the movements in the options market lately.
Are Options Traders Betting on a Big Move in MyoKardia (MYOK) Stock?
12:32pm, Tuesday, 07'th Apr 2020
Investors need to pay close attention to MyoKardia (MYOK) stock based on the movements in the options market lately.
Myokardia Inc (NASDAQ:MYOK) CEO Anastasios Gianakakos Sells 2,500 Shares of Stock
08:34am, Tuesday, 07'th Apr 2020
Myokardia Inc (NASDAQ:MYOK) CEO Anastasios Gianakakos sold 2,500 shares of the firm’s stock in a transaction dated Thursday, April 2nd. The stock was sold at an average price of $44.77, for a total
Zacks: Brokerages Expect Myokardia Inc (NASDAQ:MYOK) Will Post Earnings of -$1.38 Per Share
08:56am, Monday, 06'th Apr 2020
Equities research analysts predict that Myokardia Inc (NASDAQ:MYOK) will report earnings of ($1.38) per share for the current fiscal quarter, according to Zacks. Zero analysts have issued estimates fo
Raymond James & Associates Buys 1,794 Shares of Myokardia Inc (NASDAQ:MYOK)
08:22am, Saturday, 04'th Apr 2020
Raymond James & Associates increased its stake in shares of Myokardia Inc (NASDAQ:MYOK) by 20.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission
Sign In
Buy MYOK